Z-0417-2015 Class II Terminated

Recalled by Diagnostic Hybrids Inc — Athens, OH

FDA device recall Z-0417-2015 was initiated by Diagnostic Hybrids Inc on Oct 16, 2014 and is designated Class II. Reason for recall: Samples are quantitating incorrectly, with approximately 50% higher concentration values than previously reported and historically documented. The recall status is terminated (terminated Sep 3, 2015). Affected quantity: 171.

Recall details

Product Type
Devices
Report Date
Sep 9, 2015
Initiation Date
Oct 16, 2014
Termination Date
Sep 3, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
171

Product description

MicroVue Bb Plus EIA is packaged as a kit which contains all reagent components to perform the test. In vitro diagnostic.

Reason for recall

Samples are quantitating incorrectly, with approximately 50% higher concentration values than previously reported and historically documented.

Distribution pattern

Worldwide Distribution - USA, including AL, CO, CT, FL, KY, MN, NC, NV, OH, PA, and WA; and, the countries of Canada, China, India, and Switzerland.

Code information

Model Number A027; Lot Number 018186; (self-affixed, EDMA Code: 12 01 02 04 00; Complement Component Bb)

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0417-2015
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0417-2015. Report a data issue: hello@regdatalab.com.